ARTICLE | Distillery Therapeutics
Renal
June 27, 2017 5:22 PM UTC
Patient sample and mouse studies suggest inhibiting SMYD2 could help treat autosomal dominant polycystic kidney disease (ADPKD). In patient kidney tissue samples, SMYD2 levels were higher than in norm...
BCIQ Company Profiles